187 related articles for article (PubMed ID: 24061692)
1. Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs.
Cong W; Shen L; Xu D; Zhao L; Ruan K; Feng Y
Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):203-10. PubMed ID: 24061692
[TBL] [Abstract][Full Text] [Related]
2. [Formula screening and optimizing for the dispersible tablets of breviscapine by orthogonal experiment].
Ding Y; Huang GH
Zhong Yao Cai; 2010 Mar; 33(3):455-8. PubMed ID: 20681316
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system.
Ma Y; Li H; Guan S
Drug Dev Ind Pharm; 2015 Feb; 41(2):177-82. PubMed ID: 25113432
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
6. Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation.
Hosny KM; Mosli HA; Hassan AH
Drug Des Devel Ther; 2015; 9():465-72. PubMed ID: 25624751
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
8. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability.
Feng BL; Li HW; Zhou MY; Lu W
Zhong Yao Cai; 2011 Apr; 34(4):605-10. PubMed ID: 21809547
[TBL] [Abstract][Full Text] [Related]
9. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
Rasool BK; Fahmy SA; Galeel OW
Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
[TBL] [Abstract][Full Text] [Related]
10. [Studies on solubility enhancement of curcumin by Polyvinylpyrrolidione K30].
Xu DH; Wang S; Mei XT; Luo XJ; Xu SB
Zhong Yao Cai; 2008 Mar; 31(3):438-42. PubMed ID: 18619253
[TBL] [Abstract][Full Text] [Related]
11. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ
Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
[TBL] [Abstract][Full Text] [Related]
13. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
15. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
[TBL] [Abstract][Full Text] [Related]
16. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies.
Li W; Yi S; Wang Z; Chen S; Xin S; Xie J; Zhao C
Int J Pharm; 2011 Nov; 420(1):161-71. PubMed ID: 21884770
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.
Hou P; Ni J; Cao S; Lei H; Cai Z; Zhang T; Yu F; Tan Q
AAPS PharmSciTech; 2013 Jun; 14(2):629-38. PubMed ID: 23636816
[TBL] [Abstract][Full Text] [Related]
18. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
Zhang F; Mao J; Tian G; Jiang H; Jin Q
AAPS PharmSciTech; 2022 Jan; 23(1):65. PubMed ID: 35102461
[TBL] [Abstract][Full Text] [Related]
19. Formulation and in vitro Evaluation of Fast Dissolving Tablets of Febuxostat Using Co-Processed Excipients.
Kaur M; Mittal A; Gulati M; Sharma D; Kumar R
Recent Pat Drug Deliv Formul; 2020; 14(1):48-62. PubMed ID: 31884935
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
Sawicki E; Schellens JH; Beijnen JH; Nuijen B
Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
